ADvance II: A 12-month Double-blind, Randomized, Controlled Study to Evaluate the Safety and Effectiveness of Deep Brain Stimulation of the Fornix (DBS-f) in Patients With Mild Probable Alzheimer's Disease

Study Title
ADvance II: A 12-month Double-blind, Randomized, Controlled Study to Evaluate the Safety and Effectiveness of Deep Brain Stimulation of the Fornix (DBS-f) in Patients With Mild Probable Alzheimer's Disease
Sponsor Name
Functional Neuromodulation Ltd
NCT Number
NCT03622905
IDE Number
G110220
CMS Approval Date
2018-10-12
Category
B

https://clinicaltrials.gov/ct2/show/NCT03622905?term=NCT03622905&rank=1